ROSE DEMCZUK: Open Payments
NPI 1639237522 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,845 in 97 payments from 14 companies in 2025. Trend: 2023 $1,841 · 2024 $1,497 · 2025 $1,845
Food & beverage: $1,845
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 17 | $295 |
| Corium, LLC | 26 | $252 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $244 |
| Otsuka America Pharmaceutical, Inc. | 5 | $184 |
| ABBVIE INC. | 11 | $178 |
| Axsome Therapeutics, Inc. | 6 | $173 |
| Tris Pharma Inc | 5 | $164 |
| Alkermes, Inc. | 5 | $102 |
| Janssen Pharmaceuticals, Inc | 4 | $85 |
| Supernus Pharmaceuticals, Inc. | 3 | $63 |
Products named: REXULTI, Azstarys, CAPLYTA, VRAYLAR, Auvelity, Dyanavel XR, LYBALVI, SPRAVATO.
Industry payments across MI — which companies pay providers there.
